Oropharyngeal Candidiasis - Pipeline Review, H1 2015 Market

1. Oropharyngeal Candidiasis - Pipeline Review, H1 2015 (Type, Mode of action, Crop Type and Geography) - Size, Share, Global and China Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020 • TELEPHONE: +1 (855) 711-1555E-MAIL: help@researchbeam.com Published on : Oct 2015

2. Report Overview Summary Global Markets Direct’s, ‘Oropharyngeal Candidiasis - Pipeline Review, H1 2015’, provides an overview of the Oropharyngeal Candidiasis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Oropharyngeal Candidiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Oropharyngeal Candidiasis and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Complete Report is Available At: http://www.researchbeam.com/oropharyngeal-candidiasis-pipeline-review-h1-2015-market

3. Report Overview The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope - The report provides a snapshot of the global therapeutic landscape of Oropharyngeal Candidiasis - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Oropharyngeal Candidiasis and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Oropharyngeal Candidiasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Oropharyngeal Candidiasis pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products

4. Report Overview • Reasons to buy • - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • - Develop strategic initiatives by understanding the focus areas of leading companies • - Identify and understand important and diverse types of therapeutics under development for Oropharyngeal Candidiasis • - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • - Devise corrective measures for pipeline projects by understanding Oropharyngeal Candidiasis pipeline depth and focus of Indication therapeutics • - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

5. Table of Contents Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Oropharyngeal Candidiasis Overview 6 Therapeutics Development 7 Pipeline Products for Oropharyngeal Candidiasis - Overview 7 Pipeline Products for Oropharyngeal Candidiasis - Comparative Analysis 8 Oropharyngeal Candidiasis - Therapeutics under Development by Companies 9 Oropharyngeal Candidiasis - Therapeutics under Investigation by Universities/Institutes 10 Oropharyngeal Candidiasis - Pipeline Products Glance 11 Enquire About Report http://www.researchbeam.com/oropharyngeal-candidiasis-pipeline-review-h1-2015-market/enquire-about-report

6. FOR MORE DETAILS Visit us at : www.researchbeam.com/oropharyngeal-candidiasis-pipeline-review-h1-2015-market Stay With Us: 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com